Předměty
Publikace
- Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience2018 | Lékařská fakulta v Hradci Králové
- Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids2017 | Farmaceutická fakulta v Hradci Králové
- Streptococcus agalactiae in pregnancies complicated by preterm prelabor rupture of membranes2016 | Lékařská fakulta v Hradci Králové
- New Potentially Active Pyrazinamide Derivatives Synthesized Under Microwave Conditions2014 | Farmaceutická fakulta v Hradci Králové
- Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients2023 | Lékařská fakulta v Hradci Králové, Farmaceutická fakulta v Hradci Králové, 1. lékařská fakulta
- Better Outcome of Off-Label High-Dose Ceftazidime in Hemato-Oncological Patients with Infections Caused by Extensively Drug-Resistant Pseudomonas Aeruginosa2023 | Lékařská fakulta v Hradci Králové, 1. léka řská fakulta
- Antimycobacterial pyridine carboxamides: From design to in vivo activity2023 | Farmaceutická fakulta v Hradci Králové
- Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase2023 | Farmaceutická fakulta v Hradci Králové
- Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid2023 | Farmaceutická fakulta v Hradci Králové
- N-Pyrazinylhydroxybenzamides as biologically active compounds: a hit-expansion study and antimicrobial evaluation2023 | Farmaceutická fakulta v Hradci Králové
Loading network view...